CELLDEX THERAPEUTICS INC NEW shareholders Q2 2023

CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B902. A total of 3 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

CELLDEX THERAPEUTICS INC NEW shareholders Q2 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 11,200$380,0160.00%
SIMPLEX TRADING, LLC 6,400$2170.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%

This page lists CELLDEX THERAPEUTICS INC NEW's shareholders in Q2 2023. To view CELLDEX THERAPEUTICS INC NEW's shareholder history, click here.